With over thirty years experience in the securities and investment industry, including Director of Research at First National Bank of Maryland, Portfolio Manager of over $1.5 billion in US and Canadian equities at General Accident Insurance Company and Co- manager of the $2.3 billion Large Cap Growth Fund at BlackRock, currently Steven Ralston, CFA, is providing independent research through Zacks Small-Cap Research on small and micro cap companies in the consumer staples and resources sectors, including the mining, petroleum and alternative energy industries. As a Senior Analyst, Steven generates comprehensive investment reports on 8 companies. In his spare time, he is conducting research on the integration of proven expert systems with Chaos theory on the ultimate complex system, the U.S. equity market.
I am a senior equity analyst with over two decades of experience in the technology and TMT space, specializing in small cap technology research. I consider myself the first internet analyst on wall street and have always sought the next big thing in the tech space. I have worked extensively on both the buy-side at The Evergreen Funds and sell-side at firms including Prudential Securities, Unterberg Harris and EF Hutton.
My expertise includes valuing public and private companies in the technology arena, with a strong focus recently on TMT telecom, media, handsets, Internet, consumer electronics, digital media and software.
I have an MBA from the University of Massachusetts at Amherst, and a BSChE from Tufts University.
Anita Dushyanth is a Biotechnology Technology and Medical Devices Analyst with Zacks Investment Research.
She has worked as a researcher in the field of Bioengineering at the University of California, Los Angeles (UCLA) for over 10 years. Her expertise includes research that delves into the biomechanics of the human body, degenerative disease progression, quantitative image analysis and optimization, and design and development of medical compliant devices. She has published and presented several research articles and has also been a peer reviewer and an editor for a number of prestigious journals in the field of biomedical engineering. Prior to that, Anita worked as a researcher at the Department of Radiology and Biomedical Imaging at the University of California, San Francisco (UCSF).
Anita holds a PhD degree in Bioengineering from UCLA, M.S. in Biomedical Engineering from Wright State University, Dayton, OH and B.S. in Instrumentation Engineering from the University of Madras, India.
Nisha Hirani, M.D. is an experienced healthcare professional who serves as the Chief Scientific Advisor for Berg Capital Markets, LLC. In addition to her advisory role at Berg Capital Markets, LLC, Dr. Hirani currently works as a medical/healthcare industry consultant for NavMed Partners LLC. As a consultant, Dr. Hirani prepares proprietary client focused services including due diligence, valuation analysis, market research, and product research for biotechnology, pharmaceutical, healthcare staffing, healthcare IT and medical device companies, and is also a contributing writer for platforms such as Seeking Alpha and StockViews. Previously, Dr. Hirani worked as a biotechnology equity research analyst producing institutional quality equity research for under-valued and under-followed healthcare, biotechnology and medical device companies. Dr. Hirani’s initiating coverage reports, research reports and articles have been featured on both institutional and retail platforms including Thomson Reuters First Call, Bloomberg, Wall Street Source, Yahoo! Finance, Fidelity.com, and Google Finance. In the past, Dr. Hirani has taught embryology, performed research in the area of optical mammography, and taught English as a Second Language (ESL) classes. Dr. Hirani graduated from Tufts University with a B.S. in Biomedical Engineering and B.S in Biology, and received her Doctor of Medicine (M.D.) degree from St. George’s University School of Medicine. She completed her clinical clerkships primarily through the Barnabas Health System located in the New York Metropolitan area. In her free time, Dr. Hirani enjoys tennis, canvas painting, and volunteering for various non-profit organizations.
I am an Senior Biotech Analyst with Zacks Investment Research, Inc. I joined Zacks in February 2014.
Prior to joining Zacks, I was an NRSA Postdoctoral Fellow working in a cancer genetics laboratory.
I received my PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill. I also have my BS and MS in Biochemistry from Virginia Tech.
Andy Hecht is the chief market strategist for Carden Capital and Carden Futures. Andy is a sought-after commodity and futures trader, an options expert and analyst. He spent nearly 35 years on Wall Street, including two decades on the trading desk of Phillip Brothers, which became Salomon Brothers and ultimately part of Citigroup.
Over the past two decades, he has researched, structured and executed some of the largest trades ever made, involving huge quantities of precious metals and bulk commodities.
Andy understands the market in a way many traders can’t imagine. He’s booked vessels, armored cars and trains to transport and store a wide range of commodities. And he’s worked directly with The United Nations and the legendary trading group Phibro.
Today, Andy remains in close contact with sources around the world and his network of traders.
“I have a vast Rolodex of information in my head… so many bull and bear markets. When something happens, I don’t have to think. I just react. History does tend to repeat itself over and over.”
His friends and mentors include highly regarded energy and precious metals traders, supply line specialists and international shipping companies that give him vast insight into the market.
Andy’s writing and analysis can be found on a number of market based websites including CQG. Andy lectures at colleges and Universities. He also contributes to Traders Magazine. He consults for companies involved in producing and consuming commodities. Andy's biweekly radio show, The Commodities Hour with Andy Hecht, can be heard on Tuesdays and Thursdays from 5-6 PM EST on www.tfnn.com. Andy’s first book How to Make Money with Commodities, published by McGraw Hill was released in 2013 and has received excellent reviews. He is currently working on his second book, Luster. Andy held a Series 3 and Series 30 license from the National Futures Association and is associated as a collaborator and strategist with hedge funds. Andy is the commodity-expert for the website about.com and blogs on his own site technomentals.com.
Fincom Investment Partners focuses on mid-stage development and special opportunities in the technology and commodity sectors. Over the past 30 years our President has worked with many of the world's top-tier investors, such as Upfront Ventures, co-founded by Paul Allen and last decade’s #1 performing VC. In addition to developing a proprietary Risk vs. Reward parameter methodology, he has initiated many dozens of successful investments such as a $2 million start-up financing for Petrohawk which became a $15 Billion buyout (BHP 2011). He has been quoted in most the financial press including the WSJ, IBD, Barron’s; and in 1989 hosted “The Venture Capitalist” which aired on (now) CNBC.
Small business owner and investor. I've been involved with investing dating back to when I opened my first account at Olde Discount Brokers back in 1998 before it was purchased by H&R Block. My area of focus and ability is in value investing. I short commodities more often than I short stocks as I prefer to be a stocktimist or stock optimist by nature. I've only recently decided to become a contributor on the site as I'd like to share my research with others to help them with investing.
Specialty: Technical Analysis
Name: Michael Payne, CEO of No Payne Roofing Inc.
Objective: To share results of technical indications
Experience: Relentless market participation since November 2011
Fourth year medical student at a US medical institution pursuing an MD. I invest mostly in biotech stocks on the long and short side through both equity and option positions. I focus mostly on technical analysis, pre/post clinical trial results, FDA advisory committee meetings and drug approval events.
A former writer for the TheStreet and SA, I'm an ardent follower of financial markets and macro-developments and enjoy disseminating research and due diligence in an effort to both spark ideas for alpha and to help corroborate the findings of others. I focus on both nascent companies with potential that are well managed as well as blue-chip stalwarts that are either undervalued or possess long-term earnings growth.
Lowenthal Capital Partners is operated by Trevor Lowenthal. Trevor graduated with a BA in Political Science from University of California, Davis with Summa Cum Laude distinction. Trevor is finishing his J.D. at the University of Colorado Boulder Law School.
Trevor manages the Actionable Ideas for Maximizing Returns newsletter. Sign up for a free trial here.
Making money investing in financial markets is our livelihood. It's how we put food on the table. The partners of Cup & Handle Macro have over 50 years of combined experience, and have worked together at some of the most high-profile hedge funds in the world. We're independent now and very excited to generate out-sized returns with our readers.
We are two Masters student co-managing a small investment portfolio, where we focus on buying value with a Graham-type margin of safety, using the classical fundamental value tools as well as the tools of statistics and econometrics.
John M. Mason writes on current monetary and financial events. He is an entrepreneur and a writer. Current projects include a new banking institution, an Internet company, a private equity fund, two depository institutions and a community redevelopment fund. He formerly was on the faculty of the Finance Department, Wharton School, the University of Pennsylvania. Dr. Mason has been President and CEO of two publicly traded financial institutions and the executive vice president and CFO of a third. He has also served as a special assistant to the secretary of the Department of Housing and Urban Development in Washington, D. C. and as a senior economist within the Federal Reserve System. Dr. Mason has served on the boards of venture capital funds and other private equity funds. He has worked with young entrepreneurs, especially within the urban environment, starting or running companies primarily connected with Information Technology. Some of his new ventures are in the sustainable business and impact business space. .
Michael Ashton has been a recognized leader in developing the U.S. inflation derivatives market. He traded the first interbank U.S. CPI swaps in 2003 and, as a dealer, was a primary liquidity-provider in that market for two large banks. He represented about one-third of interbank swaps volume during his tenures at those firms. He invented and was the sole market-maker for the CME CPI Futures contract. He has written and spoken extensively about the use of inflation-indexed products for hedging real exposures, and has written more broadly in a commentary format about the rates markets and macroeconomy. Mr. Ashton is currently the managing principal at Enduring Investments LLC. His comments on this site and others are not posted in that role, and no opinions of his should be construed to be recommendations of or to reflect the views of his employer. He recently published "What's Wrong With Money? The Biggest Bubble of All."
Think B.I.G., by Bespoke Investment Group, provides some of the most original content and intuitive thinking on the Street. Founded by Paul Hickey and Justin Walters, formerly of Birinyi Associates and creators of the acclaimed TickerSense blog, Bespoke offers multiple products that allow anyone, from institutions to the most modest investor, to gain the data and knowledge necessary to make intelligent and profitable investment decisions. Along with running their Think B.I.G. finance blog, Bespoke provides timely investment ideas through its Bespoke Premium (http://bespokepremium.com/) subscription service and also manages money (http://bespokepremium.com/mm) for high net worth individuals.
Visit: Bespoke Investment Group (http://bespokeinvest.com/)
ContrarianProfits.com (http://www.contrarianprofits.com/) is a financial news and opinion website with a twist. As investment guru Rick Rule puts it, “You are either a contrarian or a victim.” In the financial world, most people are losers because they just don’t know what game they’re playing. They think they can just get “into the market” along with everyone else, do what everyone else does, and they will make money. Not likely. By the time you’ve paid commissions, spreads, fees, taxes – and suffered the consequences of inflation – you’ll be very lucky just to have as much money as you started with.
ContrarianProfits.com is a contrarian site, in the sense that we provide ideas, opinions and recommendations that often run counter to the mainstream financial press. We do this not just to be contrary, but because we’ve realized that Rick is right. You don’t make money by following the crowd; you make money by leading it.
Why is this so? Well, it’s obvious that if you do the same thing everyone else does you’ll get the same results everyone else gets. On average, and over the long run, real investment returns for the typical investor cannot exceed the rate of growth of the economy itself. Everybody can’t get richer faster than everybody else. Real economic growth in the US today averages about 3% per year; if you don’t make any mistakes, that’s about what you can expect. Few people may be satisfied with 3% per year, but most feel comfortable in the middle of the financial herd and are happy to take whatever that gets them. If you’re one of those people, you will probably not like our site. It will make you uncomfortable.
If, on the other hand, you’re willing to look at things a little differently, you’ll appreciate the views of many of our columnists, contributors and visionaries.
Here, you’ll read the views of:
Porter Stansberry (http://www.contrarianprofits.com/articles/author/porter-stansbury/)
Doug Casey (http://www.caseyresearch.com/)
Rick Rule (http://www.gril.net/about_us.htm)
Bill Bonner (http://www.contrarianprofits.com/articles/author/bill-bonner/)
Steve Sjuggerud (http://www.contrarianprofits.com/articles/author/dr-steve-sjuggerud/)
Addison Wiggin (http://www.contrarianprofits.com/articles/author/addison-wiggin/)
Chris Mayer (http://www.contrarianprofits.com/articles/author/chris-mayer/)
Dan Denning (http://www.contrarianprofits.com/articles/author/dan-denning/)
Dr. Marc Faber
Mogambu Guru (http://www.contrarianprofits.com/articles/author/mogambu-guru/)
David Moenning is Chief Investment Officer at Sowell Management Services, a registered investment advisor with more than $500 million under management. Sowell emphasizes an MPD (Modern Portfolio Diversification) approach to portfolio design which diversifies client holdings not only across asset classes but also by strategy, manager, and investment methodology. Dave began his investment career in 1980 and has been an independent money manager since 1987. Thus, Dave has been live on the firing line and investing for a living for nearly 30 years.
I have been investing personally since 2008. I graduated from UMass Lowell with my BSBA in May 2009 and received an MBA with a Finance concentration in December 2012. I am pursuing my CFA certification and have currently (as of June 2014) passed 2 of the 3 examinations.
M. Kevin Flynn has held the Chartered Financial Analyst designation since 1992. He is the President of Avalon Asset Management Company, a Registered Investment Adviser, and has worked in the investment industry since 1983.
Avalon's MarketWeek, a weekly newsletter written by Mr. Flynn and covering the stock market, economy and individual stocks has been published continuously since April 2007. For subscription information please send an email to firstname.lastname@example.org
Acting Man has been named after the title of the first chapter of Ludwig von Mises' book "Human Action" - the best treatise on economics ever written. The blog's main author is Pater Tenebrarum, an independent analyst who has been involved with financial markets for 34 years and is writing economic and market analyses for independent research organizations and a European hedge fund consultancy. Acting Man presents articles on the markets and the economy, a mixture of commentary on current events as well as economic theory and history, mainly from an Austrian School of Economics viewpoint. As more authors have joined the site, we have begun to broaden our palette a bit, but our orientation remains the same: pro-free market, anti-state, pro peace.
A lifelong student of the markets, speculator, and investor, decades of experience have forged Adam into a hardcore contrarian. He believes in buying low when others are afraid, then later selling high when others are brave. He founded the financial-market research company Zeal LLC, and continues to write acclaimed weekly and monthly subscription newsletters.
Sy Harding founded Asset Management Research Corporation in 1988 for the purpose of providing stock market and economic research to institutions and serious investors. Harding’s engineering background, coupled with his experience in operating high-tech businesses through numerous economic cycles, made it natural that the research involves technical analysis and charting, as well as analysis of the economic fundamentals that affect markets and individual stocks.
The firm publishes its research on its website at www.StreetSmartReport.com.
Harding is frequently ranked highly in the ‘Top Ten Market Timers in the U.S.’, and is quoted frequently in the financial media.
He wrote the timely 1999 book Riding the Bear – How to Prosper in the Coming Bear Market, which accurately predicted the 2000-2002 bear market. It also introduced Sy’s remarkable Seasonal Timing Strategy, which more than doubled the performance of the S&P 500 and Nasdaq in the nine years since, without a single down year even in the serious 2000-2002 bear market.
He has a new book out ‘How to Beat the Market the Easy Way’, which reveals several new seasonal timing strategies, from short-term to long-term, which have a history of out-performing the market, while exposing investors to less than 50% of market risk.
Costas began his trading career in 1998, hired by Gateway Partners, an Equity Options Trading Specialist Unit, on the Philadelphia Stock Exchange (PHLX). During his time there, Costas gained valuable experience navigating through the financial meltdown that saw the downfall of hedge fund, Long Term Capital, and the Russian Currency Crisis when trading volatility levels reached unprecedented levels.
Costas became a Senior Equity Options Market Maker for the firm, eventually leaving to join a proprietary trading desk where he made markets for large customer and institutional orders.
Costas has more than seven years of experience making options markets. He has also trained and educated several junior traders on option theory, risk analysis, and strategy.
He’s looking forward to helping self-directed investing hobbyists find success through the utilization and understanding of how options play an important role in achieving financial objectives.